Navigation Links
Genzyme in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility

Has No Foreseeable Impact on Aldurazyme Sales NOVATO, Calif., March 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility duri...

Millennium Research Group Analyst Available to Comment on FDA's Premarket Approval Recommendation of Genzyme Biosurgery's Synvisc Single-Injection Product for the Knee

WALTHAM, Mass., Dec. 12 /PRNewswire/ -- Millennium Research Group (MRG) analyst Deanna Vankessel, author of the recently published G lobal Markets for Hyaluronic Acid Viscosupplementation 2008 report, is available to offer extensive expertise on the recent FDA premarket approval recommendati...

Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease

CAMBRIDGE, Mass., May 7 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) reported today that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compound produced a meaningful impact on key cli...

Bioenvision Shareholders Approve Acquisition by Genzyme Corporation

CAMBRIDGE, Mass., and NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ ) and Bioenvision, Inc. (Nasdaq: BIVN ) announced this afternoon that Bioenvision stockholders have voted to approve the acquisition of the company by Genzyme at a reconvened special sharehold...

Delaware Court Approves Bioenvision, Genzyme Joint Petition

Special Meeting to be Reconvened on October 22 NEW YORK and CAMBRIDGE, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Bioenvision, Inc. (Nasdaq: BIVN ) and Genzyme Corporation (Nasdaq: GENZ ) announced today that the Court of Chancery of the State of Delaware granted a petition filed ...

Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company

Major Shareholder Will NOT Vote for Merger; Says 'Shareholders Have Already Spoken' by Rejecting Tender Offer at $5.60 per Share NEW YORK, Sept. 6 /PRNewswire-FirstCall/ -- Elliott Associates, L.P. (together with funds under common management), a major shareholder of Bioenvision (Nasdaq...

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

...d's top ten tenants are research institutions or A-rated public companies, including Beth Israel Deaconess Medical Center, Children's Hospital Boston, genzyme Corporation, Centocor, Inc. (a Johnson & Johnson subsidiary) and Schering Corporation. Each of BioMed's other top ten tenants publicly announced s...

BioMarin Announces Second Quarter 2009 Financial Results

... 22% increase Aldurazyme Net Sales by genzyme $39.2 1% increase Aldurazym...n increase of 1.0 percent compared to net sales by genzyme of $38.7 million for the second quarter of 2008. Net sales of Aldurazyme recorded by genzyme for the six months ended June 30, 2009 were $76.0 ...

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R)( )(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division o...
Genzyme in Medical Technology

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

Data Show Encouraging Results for a Potential New Front-Line Treatment Approach in AML CAMBRIDGE, Mass., June 2 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) reported preliminary data today from a fully-enrolled pivotal, phase 2 study examining the safety...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...e in revenue from the Company's collaboration with genzyme because the three and six months ended June 30, 20... Company received from its strategic alliance with genzyme in 2008 and the gain it recognized on the sale of ...s Highlights "During the last quarter, we and genzyme made great progress regarding mipomersen on two im...

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

...nt and commercialization of its programs, Fovea is working both independently and through collaborations with industrial partners like Dyax, Novartis, genzyme and CombinatoRx, as well as with academic teams, like the Inserm unit U968 (Vision Institute), the Rothschild Ophthalmological Foundation or the Joh...

BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

...azyme(R) (laronidase) for MPS I is manufactured by BioMarin and marketed by genzyme Corporation. About MPS IVA Mucopolysaccharidosis IVA (MPS IV...I (MPS I), a product which was developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product ...

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...opedic Biomaterials 2009 report, the US launch of genzyme Biosurgery's single-injection Synvisc-One will dri...ntly the only approved single-injection treatment, genzyme Biosurgery is positioned to benefit from this shif...thofix), DePuy, Exactech, Ferring Pharmaceuticals, genzyme Biosurgery, Integra LifeSciences, LifeNet Health, ...

PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy

...nt, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation for the development and commercialization of ataluren. PTC Therapeutics will market ataluren in the United States and Canada, while genzyme will commercialize the product in other regions of the world. The developm...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

...iled fludarabine therapy. Campath was developed by genzyme Corporation. Campath is marketed in the U.S. by Ba...preventing and treating diseases. About genzyme One of the world's leading biotechnology companies, genzyme is dedicated to making a major positive impact on ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

...led fludarabine therapy. Campath was developed by genzyme Corporation. Campath is marketed in the U.S. by B...preventing and treating diseases. About genzyme One of the world's leading biotechnology companies, genzyme is dedicated to making a major positive impact on ...

PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients

... The FDA has also granted PTC124 Subpart E designation for expedited development, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation to develop and commercialize PTC124 outside the United States and Canada. The development of PTC124 has also been supported by grants from...

BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with M...

More>>

Genzyme in Medical Products

Sepramesh Biosurgical Composite

Description:...s of a PPM mesh that has two distinct sides. One side of the mesh is coated with a layer of sodium hyaluronate and carboxymethylcellulose (similar to genzyme Biosurgery's Seprafilm® Adhesion Barrier). This coated side is bioresorbable, providing a temporary physical barrier that separates the underlying...
Company:Genzyme Biosurgery
Genzyme in Medical Dictionary

Genetics

...lar Genetics & Microbiology ... All News and Articles> ... How genzyme Can Help You Do More to Personalize TestingFor hematologic and solid tumor malignancies, genzyme provides an Antibody Library, and a FISH Probe Library. ... ... to the ...
Genzyme in Biological News

'Show me the money!' MDA greenlights grants

...ophic lateral sclerosis (ALS), or Lou Gehrig's disease, and spinal muscular atrophy. It also served as the basis for a lifesaving therapy developed by genzyme for a metabolic muscle disease called Pompe disease. At Columbia University, Schon has been awarded a three-year $400,000 grant to continue rese...

Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

...h are characterized by progressive weakness and degeneration of the skeletal muscles which control movement. The Muscular Dystrophy Association and genzyme Corporation supported the research. Several forms of Pompe disease affect more than 5,000 people in the U.S. If symptoms appear during infancy, the...
Genzyme in Biological Technology

Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise

HOLMDEL, N.J., June 30 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its qualit...

BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture

BioMarin will Continue to Manufacture; Genzyme will Continue to Market and Sell Aldurazyme NOVATO, Calif. and CAMBRIDGE, Mass., Jan. 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) and Genzyme Corporation (Nasdaq: GENZ ) announced toda...

BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors

WOBURN, Mass., Oct. 25 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that it has appointed Jan van Heek, age 58, as Chairman of the Board of Directors. Mr. van Heek is employed as a...

Cytochroma settles lawsuit with Genzyme

Madison, Wis. - Cytochroma, Inc. , a company managed by former employees of Bone Care International, has announced the settling of a lawsuit filed in August 2006 by Genzyme Corp ., the company that acquired Bone Care in 2005. The lawsuit, in which Genzyme claimed that the former Bone Care em...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

...the substantia nigra. Once CERE-120 is delivered to the brain, it provides stable, long-lasting expression of neurturin in a highly targeted fashion. genzyme Corporation (Nasdaq: GENZ ) has licensed the ex-North American rights for the development and commercialization of CERE-120 from Ceregene, an agreem...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...ed in oncology and immunology. It wasn't all good news for biotechs. genzyme shares tumbled more than 6 percent in July following an announcement that t...cient action to correct equipment maintenance and process control problems. genzyme received an FDA warning letter in February citing manufacturing deficiencie...

PTC Therapeutics Receives $2.6 Million in Government Grants

...nt, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation for the development and commercialization of ataluren. PTC Therapeutics will market ataluren in the United States and Canada, while genzyme will commercialize the product in other regions of the world. The developm...

Kuvan Receives Priority Review Status From Health Canada

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...

BioMarin to Present at the Jefferies Healthcare Conference

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...

BioMarin to Present at the Goldman Sachs Healthcare Conference

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...
Genzyme in Biological Definition

Biotechnology

...rms The top 10 publicly-traded biotechnology companies, ranked by 2003 sales, are: Amgen Genentech Serono Biogen Idec Chiron genzyme MedImmune Gilead Sciences Cephalon Millennium Pharmaceuticals Biotechnology in fiction Star Trek The Breen use starship...
Genzyme in Biological Dictionary

Oligonucleotide

...lysis of oligonucleotide microarray design criteria to detect ... Supplying Every Link in the Peptide Chain – developed through the Mimotopes – genzyme Pharmaceuticals Global Alliance, providing seamless transition from supply of ... Oligonucleotide Oligo thermodynamic annealing temperature me...
Other Tags
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
(Date:4/17/2014)... new early-warning signs of the potential loss of sight ... for the diagnosis and treatment of diabetic retinopathy, potentially ... "We had not expected to see such striking changes ... Elsner, professor and associate dean in the IU School ... set out to study the early signs, in volunteer ...
(Date:4/17/2014)... wild animals and plant life, but there,s an invisible ... in the soil, decomposing organic matter and releasing carbon ... fungi play in ecological systems, their identities have only ... generated a genetic map of more than 10,000 species ... this week in the Proceedings of the National ...
(Date:4/17/2014)... View of Domestication," a special feature of The ... ( PNAS ) published April 29, raises a ... deep history that most of us take for granted. ... in many spots around the globe shifted from hunting ... and plants. , It seems so straightforward and yet ...
Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
Other Contents